These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1472665)

  • 1. Variations of blood PAF-acether levels during coronary artery surgery.
    Nathan N; Denizot Y; Feiss P; Laskar M; Arnoux B; Benveniste J
    J Cardiothorac Vasc Anesth; 1992 Dec; 6(6):692-6. PubMed ID: 1472665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations in blood platelet-activating-factor levels after protamine reversal of heparin in humans.
    Nathan N; Denizot Y; Feiss P; Cornu E; Benveniste J; Arnoux B
    Acta Anaesthesiol Scand; 1992 Apr; 36(3):264-9. PubMed ID: 1574976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.
    Burhop KE; van der Zee H; Bizios R; Kaplan JE; Malik AB
    Am Rev Respir Dis; 1986 Sep; 134(3):548-54. PubMed ID: 3752711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of paf-acether in rheumatic diseases.
    Hilliquin P; Menkes CJ; Laoussadi S; Benveniste J; Arnoux B
    Ann Rheum Dis; 1992 Jan; 51(1):29-31. PubMed ID: 1540032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine and lipid mediator blood concentrations after coronary artery surgery.
    Nathan N; Denizot Y; Cornu E; Jauberteau MO; Chauvreau C; Feiss P
    Anesth Analg; 1997 Dec; 85(6):1240-6. PubMed ID: 9390587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
    Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
    J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins.
    Benveniste J; Nunez D; Duriez P; Korth R; Bidault J; Fruchart JC
    FEBS Lett; 1988 Jan; 226(2):371-6. PubMed ID: 3338565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.
    Benveniste J; Roubin R; Chignard M; Jouvin-Marche E; Le Couedic JP
    Agents Actions; 1982 Dec; 12(5-6):711-3. PubMed ID: 7164945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A; Milazzo N; Miadonna A
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anaphylactic release of platelet-activating factor from perfused guinea-pig lungs.
    Fitzgerald MF; Moncada S; Parente L
    Br J Pharmacol; 1986 May; 88(1):149-53. PubMed ID: 3708213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The actions of Paf-acether (platelet-activating factor) on guinea-pig isolated heart preparations.
    Benveniste J; Boullet C; Brink C; Labat C
    Br J Pharmacol; 1983 Sep; 80(1):81-3. PubMed ID: 6652376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
    Touqui L; Jacquemin C; Vargaftig BB
    Biochem Biophys Res Commun; 1983 Feb; 110(3):890-3. PubMed ID: 6838557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.
    Stephens CJ; Graham RM; Yadava OP; Leong LL; Sturm MJ; Taylor RR
    Cardiovasc Res; 1992 Jan; 26(1):25-31. PubMed ID: 1516109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs.
    Fiedler VB; Mardin M; Abram TS
    Basic Res Cardiol; 1987; 82(2):197-208. PubMed ID: 3606544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous injections of PAF-acether induce platelet aggregation in rats.
    Martins MA; Martins PM; Faria Neto HC; Bozza PT; Dias PM; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1988 Apr; 149(1-2):89-96. PubMed ID: 3135199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
    Jouvin-Marche E; Poitevin B; Benveniste J
    Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
    Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
    Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.